FIELD: veterinary medicine.
SUBSTANCE: group of inventions refers to veterinary science, namely to immunology, and can be used for using the vaccine to reduce asymptomatic extraction of Lawsonia intracellularis bacteria in pigs. Vaccine containing a non-living Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier is used in pigs with subclinical Lawsonia intracellularis infection, used by systemic administration. Group of inventions also relates to a method for reducing asymptomatic recovery of Lawsonia intracellularis bacteria in pigs.
EFFECT: using the given group of inventions enables reducing asymptomatic recovery of Lawsonia intracellularis bacteria in pigs using this vaccine.
10 cl, 3 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE FOR USE AGAINST SUBCLINICAL LAWSONIA INFECTION IN PIGS | 2016 |
|
RU2723022C2 |
| VACCINE AGAINST LAWSONIA INTRACELLULARIS | 2009 |
|
RU2523561C2 |
| Lawsonia-BASED VACCINE AND METHODS OF ITS APPLICATION | 2006 |
|
RU2420310C2 |
| VACCINE FOR PROTECTION AGAINST LAWSONIAINTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCOVIRUS | 2009 |
|
RU2496520C2 |
| SWINE VACCINE AGAINST PRRS AND LAWSONIA INTRACELLULARIS | 2014 |
|
RU2655615C1 |
| VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
| VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
| PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
| COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
| Lawsonia intracellulars OF EUROPEAN ORIGIN AND BASED VACCINES, DIAGNOSTIC AGENTS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2420570C2 |
